Rathbones Group PLC Gsk PLC Transaction History

Rathbones Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$36.52 - $41.46 $212,729 - $241,504	-5,825 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$34.27 - $40.01 $30,843 - $36,009	-900 Reduced 13.38%	5,825 $208,000
Q2 2020 Aug 07, 2020	SELL	$37.87 - $43.58 $5,718 - $6,580	-151 Reduced 2.2%	6,725 $274,000
Q1 2018 Apr 06, 2018	SELL	$36.18 - $40.15 $28,944 - $32,120	-800 Reduced 10.42%	6,876 $269,000
Q4 2017 Jan 24, 2018	SELL	$35.34 - $41.9 $60,078 - $71,230	-1,700 Reduced 18.13%	7,676 $272,000
Q3 2017 Oct 24, 2017	BUY	$39.44 - $41.55 $369,789 - $389,572	9,376	9,376 $381,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

Stay updated on Rathbones Group PLC with notifications on news.